Your typical patient with a gambling disorder may not fit yesterday’s stereotype.

First approved in 2002, Suboxone, a sublingual pill, was undoubtedly a breakthrough in opiate addiction treatment—especially as compared to methadone. Unlike methadone, Suboxone could be prescribed in the office and filled at pharmacies, freeing patients from the shackles of the methodone lifestyle and its required daily clinic visits.

Learn about Internet gaming disorder, the problems it causes patients, and the best way to treat it, in an interview with Nancy Petry, PhD.

After reading these articles, you should be able to…

The ASAM Criteria—the American Society of Addiction Medicine’s guidelines for addiction treatment—are not just a tool for program administrators and insurance bureaucrats. They provide a useful conceptual framework for thinking about your patients and what kind of care they need.

Find out what the FDA’s Risk Evaluation and Mitigation Strategies (REMS) program focusing on extended-release and long-acting opioid analgesic medications is all about, in an interview with Edwin A. Salsitz, MD.

Learn how you can use The ASAM Criteria to determine what kind of care a patient with an addiction needs and help ensure funding for that treatment, in an interview with David Mee-Lee, MD.

Addiction and violence are often linked. Despite this, few studies have looked at whether substance abuse treatment reduces aggressive behavior.

After reading these articles, you should be able to…

Today’s conversation about “smart drugs” is fundamentally different and refers to the use of medications by people without psychiatric disorders who seek a boost or cognitive edge.